Some studies with postmortem human brains report elevations in BACE1 mRNA levels associated with sporadic AD [46], [47], while others show no changes in mRNA despite the increased levels of BACE1 activity and protein [48]–[51]. The gene discussed is BACE1; the disease is Alzheimer disease.